HM
HealthCor Management Portfolio holdings
AUM
$109M
Turnover
75.38%
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$109M
AUM Growth
-$690M
(-86%)
Cap. Flow
-$711M
Cap. Flow
% of AUM
-651.32%
Top 10 Holdings %
Top 10 Hldgs %
91.26%
Holding
65
New
6
Increased
2
Reduced
11
Closed
43
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$7.45M |
| 2 |
Acrivon Therapeutics
ACRV
|
+$3.61M |
| 3 |
CONMED
CNMD
|
+$2.28M |
| 4 |
Intuitive Surgical
ISRG
|
+$1.4M |
| 5 |
Hyperfine
HYPR
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$41.6M |
| 2 |
Agilent Technologies
A
|
+$41.1M |
| 3 |
Boston Scientific
BSX
|
+$37.1M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$36.7M |
| 5 |
Eli Lilly
LLY
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.98% |
| 2 | Miscellaneous | 0.02% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
DELISTED
Affimed
AFMD
| – | – |
-172,193
| Closed | -$3.55M | – |
|
27
Amgen
AMGN
$230B
| – | – |
-75,370
| Closed | -$17M | – |
|
28
Becton Dickinson
BDX
$51.5B
| – | – |
-62,930
| Closed | -$14M | – |
|
29
Biogen
BIIB
$34.4B
| – | – |
-69,950
| Closed | -$18.7M | – |
|
30
DELISTED
bluebird bio
BLUE
| – | – |
-22,750
| Closed | -$2.88M | – |
|
31
Bristol-Myers Squibb
BMY
$121B
| – | – |
-223,150
| Closed | -$15.9M | – |
|
|
32
Boston Scientific
BSX
$62.3B
| – | – |
-958,600
| Closed | -$37.1M | – |
|
33
Cigna
CI
$76.5B
| – | – |
-76,910
| Closed | -$21.3M | – |
|
34
Centene
CNC
$34.7B
| – | – |
-300,970
| Closed | -$23.4M | – |
|
35
Cencora
COR
$64.2B
| – | – |
-239,150
| Closed | -$32.4M | – |
|
36
CVS Health
CVS
$116B
| – | – |
-131,150
| Closed | -$12.5M | – |
|
37
Danaher
DHR
$158B
| – | – |
-132,878
| Closed | -$30.4M | – |
|
38
Elevance Health
ELV
$92.8B
| – | – |
-38,910
| Closed | -$17.7M | – |
|
39
DELISTED
Hologic
HOLX
| – | – |
-137,330
| Closed | -$8.86M | – |
|
40
Henry Schein
HSIC
$9.54B
| – | – |
-248,920
| Closed | -$16.4M | – |
|
41
Humana
HUM
$51.3B
| – | – |
-42,920
| Closed | -$20.8M | – |
|
42
ImageneBio Inc
IMA
$47.1M
| – | – |
-18,340
| Closed | -$781K | – |
|
43
Incyte
INCY
$22.6B
| – | – |
-227,851
| Closed | -$15.2M | – |
|
44
DELISTED
Kezar Life Sciences
KZR
| – | – |
-160,765
| Closed | -$13.8M | – |
|
45
LivaNova
LIVN
$4.19B
| – | – |
-328,030
| Closed | -$16.7M | – |
|
|
46
Eli Lilly
LLY
$1.08T
| – | – |
-103,150
| Closed | -$33.4M | – |
|
47
Cypherpunk Technologies Inc
CYPH
$282M
| – | – |
-106,669
| Closed | -$939K | – |
|
48
McKesson
MCK
$114B
| – | – |
-35,040
| Closed | -$11.9M | – |
|
49
Molina Healthcare
MOH
$10.9B
| – | – |
-27,540
| Closed | -$9.08M | – |
|
50
DELISTED
Merus
MRUS
| – | – |
-272,890
| Closed | -$5.47M | – |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q4 2022 Portfolio in Review
As of Q4 2022, HealthCor Management held 65 positions worth $109M, down 86% from $800M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
HealthCor Management withdrew a net $711M in Q4 2022, closing 43 positions and reducing 11 holdings. Its most notable exit was AbbVie, an estimated $41.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, HealthCor Management opened a new position in Acrivon Therapeutics worth $3.27M.
- HealthCor Management's largest Q4 2022 buy was Acrivon Therapeutics: 284,201 shares worth $3.27M.
- HealthCor Management added most to DexCom in Q4 2022, an estimated $7.45M increase.
- HealthCor Management's biggest Q4 2022 reduction was BioMarin Pharmaceuticals, cutting an estimated $36.7M.
- HealthCor Management fully exited AbbVie in Q4 2022, selling an estimated $41.6M.
- HealthCor Management's ten largest holdings make up 91% of its $109M portfolio in Q4 2022.
- HealthCor Management opened 6 new positions and closed 43 in Q4 2022.
- HealthCor Management's portfolio value fell 86% quarter-over-quarter to $109M.
Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.